Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Cash from Financing Activities (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Cash from Financing Activities for 16 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 134.47% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Dec 2025, up 393.23% year-over-year, with the annual reading at $7.2 million for FY2025, 393.23% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $3.8 million at Creative Medical Technology Holdings, up from $3.4 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $15.5 million in Q2 2022, with the low at -$191780.0 in Q3 2023.
  • Average Cash from Financing Activities over 5 years is $2.6 million, with a median of $362116.5 recorded in 2021.
  • The sharpest move saw Cash from Financing Activities surged 14552.69% in 2022, then tumbled 1598266.67% in 2023.
  • Over 5 years, Cash from Financing Activities stood at $9.3 million in 2021, then plummeted by 100.0% to $12.0 in 2022, then tumbled by 659866.67% to -$79172.0 in 2023, then soared by 2158.18% to $1.6 million in 2024, then soared by 134.47% to $3.8 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $3.8 million, $3.4 million, and $1.6 million for Q4 2025, Q1 2025, and Q4 2024 respectively.